REQUEST A DEMO
Total
USD $0.00
Search more companies

Unidad De Diagnostico Neurofisiologico Ips S.A.S En Liquidacion (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Diagnostic Imaging Centers
Full name: Unidad De Diagnostico Neurofisiologico Ips S.A.S En Liquidacion Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English & Spanish Download a sample report

Unidad De Diagnostico Neurofisiologico Ips S.A.S En Liquidacion is an enterprise in Colombia, with the main office in Ibague. It operates in the Ambulatory Health Care Services industry. It was incorporated on September 10, 2014. From the latest financial highlights, Unidad De Diagnostico Neurofisiologico Ips S.A.S En Liquidacion reported a net sales revenue increase of 73.15% in 2021. Its’ total assets recorded a negative growth of 5.79%. The net profit margin of Unidad De Diagnostico Neurofisiologico Ips S.A.S En Liquidacion increased by 8.42% in 2021.

Headquarters
Cra 12 Sur N 93 - 21 Clinica Medicadiz Tor
Ibague; Tolima;

Contact Details: Purchase the Unidad De Diagnostico Neurofisiologico Ips S.A.S En Liquidacion report to view the information.

Basic Information
Outstanding Shares:
Purchase the Unidad De Diagnostico Neurofisiologico Ips S.A.S En Liquidacion report to view the information.
Incorporation Date:
September 10, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Unidad De Diagnostico Neurofisiologico Ips S.A.S En Liquidacion report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
73.15%
Total operating revenue
73.15%
Operating profit (EBIT)
-23.53%
Net Profit (Loss) for the Period
-14.88%
Total assets
-5.79%
Total equity
-7.77%
Operating Profit Margin (ROS)
6.97%
Net Profit Margin
8.42%
Return on Equity (ROE)
-1.66%
Quick Ratio
-8.41%
Cash Ratio
-4.71%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?